APA (7th ed.) Citation

Chaovanitkul, C., Onchan, T., Pongkulkiat, P., Mahakkanukrauh, A., Suwannaroj, S., & Foocharoen, C. (2025). Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset. MDPI AG.

Chicago Style (17th ed.) Citation

Chaovanitkul, Chana, Tippawan Onchan, Patnarin Pongkulkiat, Ajanee Mahakkanukrauh, Siraphop Suwannaroj, and Chingching Foocharoen. Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset. MDPI AG, 2025.

MLA (9th ed.) Citation

Chaovanitkul, Chana, et al. Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset. MDPI AG, 2025.